S2k-Leitlinie der PEG zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen
| Autor: | O. R. Frey, K. F. Bodmann, A. Brinkmann, Michael Kresken, W. Krüger, D. C. Richter, B. Grabein, A. C. Röhr, Thorsten Brenner |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty business.industry Septic shock medicine.drug_class 030106 microbiology Antibiotics General Medicine Evidence-based medicine medicine.disease Intensive care unit law.invention Sepsis 03 medical and health sciences 0302 clinical medicine Anesthesiology and Pain Medicine Pharmacotherapy law Infectious disease (medical specialty) Medicine Initial treatment 030212 general & internal medicine business Intensive care medicine |
| Zdroj: | Der Anaesthesist. 67:936-949 |
| ISSN: | 1432-055X 0003-2417 |
| DOI: | 10.1007/s00101-018-0512-8 |
| Popis: | In January 2018 the recent revision of the S2k guidelines on calculated parenteral initial treatment of bacterial diseases in adults-update 2018 (Editor: Paul Ehrlich Society for Chemotherapy, PEG) was realized. It is a helpful tool for the complex infectious disease setting in an intensive care unit. The present summary of the guidelines focuses on the topics of anti-infective agents, including new substances, pharmacokinetics and pharmacodynamics as well as on microbiology, resistance development and recommendations for calculated drug therapy in septic patients. As in past revisions the recent resistance situation and results of new clinical studies are considered and anti-infective agents are summarized in a table. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink